Prevalence and characterization of extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Korean hospitals

被引:48
作者
Ko, Kwan Soo [2 ,3 ]
Lee, Mi Young [3 ]
Song, Jae-Hoon [1 ,3 ]
Lee, Hyuck [5 ]
Jung, Dong Sik [5 ]
Jung, Sook-In [6 ]
Kim, Shin-Woo [7 ]
Chang, Hyun-Ha [7 ]
Yeom, Joon-Sup [8 ]
Kim, Yeon-Sook [9 ]
Ki, Hyun Kyun [10 ]
Chung, Doo-Ryeon [1 ]
Kwon, Ki Tae [11 ]
Peck, Kyong Ran [1 ]
Lee, Nam Yong [4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea
[3] Asian Pacific Res Fdn Infect Dis, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul 135710, South Korea
[5] Dong A Univ Hosp, Pusan 602715, South Korea
[6] Chonnam Natl Univ, Sch Med, Kwangju 501757, South Korea
[7] Kyungpook Natl Univ Hosp, Taegu 700721, South Korea
[8] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med, Seoul 110746, South Korea
[9] Chungnam Natl Univ Hosp, Taejon 301721, South Korea
[10] Konkuk Univ Hosp, Seoul 143729, South Korea
[11] Daegu Fatima Hosp, Taegu 701600, South Korea
关键词
extended-spectrum beta-lactamases (ESBLs); Klebsiella pneumoniae; Escherichia coli;
D O I
10.1016/j.diagmicrobio.2008.03.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Prevalence and characteristics of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaccae in Korean hospitals were assessed. A total of 1484 clinical Enterobacteriaceae isolates were collected from 8 tertiary-care hospitals in various regions of Korea over a 3-month period (June to August) in 2005. Among 546 Klebsiella pneumoniae isolates, 123 isolates (22.4%) showed ESBL-producing activity, and 47 (10.2%) of 460 isolates of Escherichia coli were ESBL producers. Of the Enterobacter cloacae isolates, 16.2% (17/105) evidenced ESBL-producing activity. The most prevalent ESBLs were SHV-12 and CTX-M-14 in K. pneumoniae and E. coli, respectively. In E. cloacae, SHV-12 was also the most prevalent. Prevalence of ESBL production differed among the specimens. Although the K. pneumoniae isolates from urine and aspirates evidenced high ESBL production rates (35.4% and 57.1%, respectively), those from sputum, blood, and pus showed relatively low ESBL production rates (17.0%, 14.8%, and 5.3%, respectively). However, E. coli isolates obtained from sputum showed significantly higher ESBL production rates (37.5%) than were seen in samples obtained from other sources, but those obtained from urine showed lower ESBL production rates (8.3%). These significant differences in ESBL-producing K. pneumoniae and E. coli isolates among the isolated specimens should be examined further, with an eye toward the implications of this research in clinical settings. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 27 条
[1]   Extended-spectrum β-lactamases in the 21st century:: Characterization, epidemiology, and detection of this important resistance threat [J].
Bradford, PA .
CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) :933-951
[2]   Metallo-β-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient [J].
Cardoso, Olga ;
Alves, Ana Florinda ;
Leitao, Rui .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 31 (04) :375-379
[3]  
*CLIN LAB STAND I, 2006, M100S16 CLSI
[4]   The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs [J].
Cosgrove, SE .
CLINICAL INFECTIOUS DISEASES, 2006, 42 :S82-S89
[5]   Regional variation in the prevalence of extended-spectrum β-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002) [J].
Hirakata, Y ;
Matsuda, J ;
Miyazaki, Y ;
Kamihira, S ;
Kawakami, S ;
Miyazawa, Y ;
Ono, Y ;
Nakazaki, N ;
Hirata, Y ;
Inoue, M ;
Turnidge, JD ;
Bell, JM ;
Jones, RN ;
Kohno, S .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (04) :323-329
[6]   Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species [J].
Hyle, EP ;
Lipworth, AD ;
Zaoutis, TE ;
Nachamkin, I ;
Fishman, NO ;
Bilker, WB ;
Mao, XQ ;
Lautenbach, E .
CLINICAL INFECTIOUS DISEASES, 2005, 40 (09) :1317-1324
[7]   Mechanisms of disease:: The new β-lactamases [J].
Jacoby, GA ;
Munoz-Price, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (04) :380-391
[8]   Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Eschetichia coli from a Korean nationwide survey [J].
Jeong, SH ;
Bae, IK ;
Lee, JH ;
Sohn, SG ;
Kang, GH ;
Jeon, GJ ;
Kim, YH ;
Jeong, BC ;
Lee, SH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (07) :2902-2906
[9]   Investigation of extended-spectrum β-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea [J].
Jeong, SH ;
Bae, IK ;
Kwon, SB ;
Lee, JH ;
Jung, HI ;
Song, JS ;
Jeong, BC ;
Kim, SJ ;
Lee, SH .
LETTERS IN APPLIED MICROBIOLOGY, 2004, 39 (01) :41-47
[10]   Dissemination of transferable CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli in Korea [J].
Jeong, SH ;
Bae, IK ;
Kwon, SB ;
Lee, JH ;
Song, JS ;
Jung, HI ;
Sung, KH ;
Jang, SJ ;
Lee, SH .
JOURNAL OF APPLIED MICROBIOLOGY, 2005, 98 (04) :921-927